Morning Report | Hormuz toll-blockade risk spikes, energy shock bid hits global risk
$FXI June trade beat, pull-forward risk $ITA Section 815 buyback limits watch $XLY Retail Monitor steady demand, apparel leads $URA Utah monuments cut, uranium option bid $FXI tariff-shift risk
Market Pulse
U.S.-Iran War
4 events
Hormuz disruption risk rises as U.S. strike tempo and new toll-blockade plan collide with falling ship traffic and direct tanker attacks.
Latest Development
President Trump said the U.S. will impose a 20% cargo fee in the Strait of Hormuz and reinstate a blockade of Iranian ports, with CENTCOM saying the blockade is effective Tuesday 4:00 p.m. ET.
CENTCOM reported a five-hour, third-straight-night strike wave targeting Iranian coastal defenses plus missile, drone, and maritime sites as UAE officials said two national tankers were hit by Iranian cruise missiles in the strait.
Trump’s July 10 letter to Congress said U.S. military action against Iran restarted July 7 after tanker attacks near Hormuz, while lawmakers dispute whether War Powers timelines were reset by an earlier ceasefire.
The U.S. Energy Department said over 8 million barrels transited Hormuz Sunday with U.S. military assistance as Kpler data showed 14 ships crossing versus 37 a week earlier, with reports of route shifts and transponders turned off.
Market reaction
Oil extended a sharp risk-premium move: WTI (Aug) was quoted about +3.3% to ~$80.75 and Brent (Sep) about +4.5% to ~$87.01 in early Tuesday trade after a ~9.6% prior-session jump, with higher energy-sensitive breakevens cited as pressuring duration; war-risk premiums were also flagged as rising.
Our view
A sustained elevated oil risk premium with high intraday volatility into the Tuesday 4 p.m. ET implementation window as traders price enforcement and further shipping disruption. The key monitor is whether transit volumes and war-risk premiums stabilize after the toll/blockade decision, or deteriorate alongside additional strikes and tanker incidents.
What could change our view
Non-implementation or rapid rollback of toll/blockade compresses the risk premium.
Broader or more effective attacks materially reduce crossings and reprice oil higher.
Tickers: $CL=F
Macro & Policy Digest
China’s June trade beat was outsized, lifting the growth signal but raising pull-forward risk ahead of potential U.S. tariff shifts.
Latest Development
June customs data showed exports +27% y/y and imports +26% y/y (definitions disputed), with U.S.-bound shipments up ~14% amid tariff-frontloading; crude imports fell 41% y/y.
Our view
We expect the strong June trade print to support China equities tactically, but treat it as a timing boost rather than durable demand. Monitor the July 24 tariff deadline and the finalized customs breakdown for signs that exports and import strength can persist without further frontloading.
What could change our view
Post-July export momentum fades as frontloaded U.S. orders unwind.
Tariff actions after July 24 materially reduce U.S.-bound shipments.
Tickers: $FXI
Senate NDAA debate puts Section 815 buyback and dividend limits for DoD contractors in focus ahead of possible floor amendments.
Latest Development
Senate Armed Services Committee NDAA includes Section 815 requiring Pentagon vendors to forgo buybacks and dividends unless granted a Defense Secretary waiver tied to a qualifying investment plan, effective June 15, 2027.
Our view
Section 815 is softened or removed before final passage, limiting near-term valuation impact on defense equities. Watch this week’s Senate floor process for a 60-vote amendment outcome and how House-Senate reconciliation treats the provision.
What could change our view
Section 815 survives Senate vote and conference largely intact.
Waiver standards expand, broadening compliance costs across lower-tier vendors.
Tickers: $ITA
NRF Retail Monitor points to steady June consumer demand, with ex-auto/gas sales up 0.33% m/m and apparel leading gains.
Latest Development
• June NRF retail sales ex-autos and gas rose 0.33% m/m SA and 9.41% y/y NSA; core retail sales gained 0.36% m/m SA and 10.08% y/y, with clothing up 0.63% m/m.
Our view
We lean to a constructive near-term read-through for consumer-discretionary fundamentals into earnings, with NRF data reinforcing a soft-landing-consumption narrative if confirmed. Next check is the official Census retail sales print and category mix, given methodology differences that can distort direct extrapolation.
What could change our view
Census retail sales contradicts NRF nowcast, undermining discretionary revenue expectations.
Apparel-led strength fades, reversing category momentum implied by June monitor.
Tickers: $XLY
Trump’s Antiquities Act proclamations slash two Utah monuments by ~90%, boosting uranium and coal optionality while legal and permitting timelines stay uncertain.
Latest Development
• Trump issued proclamations cutting Bears Ears and Grand Staircase–Escalante to under ~303,000 acres combined from over 3.2 million, potentially reopening uranium- and coal-bearing areas to mining and drilling.
Our view
This is a sentiment tailwind for U.S.-listed uranium exposure (URA and miners) via higher domestic supply optionality, but it remains more narrative than near-term earnings driver. Track litigation outcomes and Interior/BLM permitting progress for any shift from optionality to actionable development timelines.
What could change our view
Court challenges overturn the proclamations, restoring monument protections and access limits.
BLM permitting and infrastructure constraints delay projects, dulling any tradable upside.
Tickers: $URA
Company Events
Bank earnings open with JPM’s record quarter and higher 2026 NII outlook, while Unity Bancorp shows steady profitability and a 4.56% NIM.
Latest Development
JPMorgan posted record Q2 net income $21.2bn (+41% YoY) including a $4.6bn Visa gain; trading revenue rose 35% to $12.1bn and it raised 2026 NII outlook to $105.5bn.
Unity Bancorp reported Q2 net income $14.5m ($1.42/sh) versus Q1 $14.3m; ROAA 2.01%, ROAE 15.86%, and NIM 4.56%, with about $3.2bn assets and $2.5bn deposits.
Our view
Bank earnings tone skews constructive, led by JPM’s markets-driven beat and higher 2026 NII guidance, while smaller-bank profitability holds steady at a high NIM. Watch whether expense growth and card charge-off trends stay contained as more banks report.
What could change our view
Non-interest expense growth overwhelms revenue gains, compressing operating leverage.
Consumer credit tightens materially, reversing the improving card charge-off outlook.
Tickers: $JPM, $UNTY
Biotech deal tape picks up as NextCure agrees reverse-merger with Avere plus $320m PIPE, while Spero signs ex-Greater China licensing pact.
Latest Development
NextCure signed an all-stock merger with private Avere, targeting a 2H 2026 close and a rename to Avere Therapeutics trading as AVRX; NXTC holders expected to own ~1.21% at close.
Spero licensed SP001/IBI355 rights ex-Greater China from Innovent in a deal valued at about $1.1bn including upfront, milestones and tiered royalties; Phase 2 IgG4-RD is targeted for Q2 2027.
Our view
Treat these as company-specific catalysts rather than a read-through for XBI/IBB, with valuation driven by financing terms and development timelines. Watch NXTC pre-close net-cash adjustment and PIPE/convert mechanics, and any disclosed SPRO upfront and Phase 2 execution milestones.
What could change our view
NXTC net-cash adjustment or deal close timing shifts materially from 2H 2026.
SPRO fails to secure meaningful upfront economics or delays Phase 2 starts into 2027.
Tickers: $NXTC, $SPRO
TSEM jumps premarket after $3B Japan fab expansion backed by $1B grants, targeting 300mm silicon photonics and higher 2028 targets.
Latest Development
• Tower Semiconductor outlined a two-phase Japan build: convert Arai to 300mm silicon photonics with full operations by Q4 2027, plus a new adjacent 300mm fab; raised 2028 revenue/profit targets.
Market reaction
TSEM shares were indicated up more than 18% premarket following the Japan investment, subsidy support, and higher 2028 targets (per Reuters).
Our view
The grant-supported Japan expansion improves TSEM’s medium-term earnings power and positioning in silicon photonics and adjacent specialty nodes, supporting a higher valuation into 2028. Next key monitor is execution against the Q4 2027 ramp and clarity on Phase 2 capacity and net company funding under program terms.
What could change our view
Delays or cost overruns push Arai 300mm photonics ramp beyond Q4 2027.
Grant terms or Phase 2 scope changes reduce net funding and 2028 targets.
Tickers: $TSEM
UMC’s Singapore fab begins mass production of silicon photonics wafers, extending foundry exposure to AI-driven optical interconnect demand ahead of 2027 platform rollout.
Latest Development
- UMC said it moved a silicon photonics platform to production readiness in 18 months with SILITH Technology, started mass production in Singapore, and targets a 12-inch platform for customer product development by 2027.
Our view
This silicon photonics ramp is an incremental medium-term growth lever for UMC rather than a near-term earnings step-change. Watch for disclosed customer engagement and the timeline to a broadly available 12-inch process design kit as proof points that production converts into repeatable volume.
What could change our view
Delays or yield issues push out 12-inch silicon photonics readiness beyond 2027.
AI/hyperscaler optical interconnect demand underdelivers, limiting volume uptake despite production.
Tickers: $UMC
SpaceX post-IPO slide persists as FAA closes Starship booster review and Flight 13 launch window opens Thursday evening.
Latest Development
SpaceX fell 4.24% Monday after 4.51% Friday, nearing the reported $135 IPO price; FAA accepted corrective actions on a May booster failure, enabling Flight 13 operations pending safety/licensing for Thursday 6:45 p.m. ET.
Market reaction
SpaceX shares extended their post-IPO selloff, down 4.24% Monday after a 4.51% drop Friday, and are about 7% below the first trade around $150 as they drift toward the reported $135 IPO price.
Our view
SPACEX remains a high-beta, event-driven trade into Flight 13, with the FAA closure modestly supportive but insufficient to offset risk-off positioning. A clean Flight 13 outcome and steady licensing updates are the key conditions to stabilize sentiment and refocus attention on post-inclusion flow dynamics.
What could change our view
Flight 13 mishap or delay reignites regulatory scrutiny and deepens the post-IPO drawdown.
Nasdaq-100 passive flows reverse, amplifying volatility around a stock near IPO price.
Tickers: $SPACEX
Go deeper -
For intraday developments, follow our Midday posts.
For the close, the wrap, and next-day trade ideas, read the Evening Memo.
For deeper work, Forward Valuation covers multi-week single-name setups (paid subscribers only).
Deep Dive is where we publish our full thematic research for paid subscribers.
Informational only; not investment advice. Sources deemed reliable.